ACT Signature Webinars

Implications for Tox/TK When ISR Fails 

12-04-2014 05:14 PM

Speakers:  Elizabeth A. Groeber, PhD, Director, Bioanalytical Services, WIL Research
Andy Vick, PhD, Senior Director, Analytical Services, WIL Research

In collaboration with: Britishish Toxicology Society and the Society of Toxicologic Pathology

Incurred Sample Reproducibility (ISR), also called Incurred Sample Reanalysis, has been a primary testing requirement according to FDA and EMA regulatory guidance since approximately 2008. The Bioanalytical laboratories conducting these tests have accumulated a significant body of experience in running ISR, performing investigations into ISR failures, and developing an understanding of the impact of ISR data. In this Webinar, ISR fundamentals (What is it and how does it affect my program?) will be discussed with the Study Direct/Toxicologist in mind. Case examples of ISR failure will be presented along with interpretation and impact to TK data as well as an overall assessment of toxicological study impact.

View Webinar Recording

Webinar materials are property of the speaker and the American College of Toxicology and are intended for use by the host society and cohost societies' members for educational purposes only. Any distribution or copy of the materials is prohibited. By downloading from the link provided you agree to the terms expressed above.

0 Favorited
1 Files
pdf file
Groeber_Vick_ACT2014_Final.pdf   378 KB   1 version
Uploaded - 08-27-2020

Related Entries and Links

No Related Resource entered.